Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: Case report with 8-year follow up
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hepatocellular carcinoma (HCC) is the sixth most common cause of death worldwide and the main cause of primary liver cancer. The principle problem of HCC is the poor prognosis, since advanced HCC reportedly has a median survival of only 9 months. The standard therapies are sorafenib and regorafenib, but the outcomes remain unclear. We report a 60-year-old man with advanced HCC with right adrenal gland metastasis and portal vein tumor thrombosis, who showed a complete response to multiple applications of an interdisciplinary therapy.
Abstract
Hepatocellular carcinoma (HCC) is the sixth most common cause of death worldwide and the main cause of primary liver cancer. The principle problem of HCC is the poor prognosis, since advanced HCC reportedly has a median survival of only 9 months. The standard therapies are sorafenib and regorafenib, but the outcomes remain unclear. We report a 60-year-old man with advanced HCC with right adrenal gland metastasis and portal vein tumor thrombosis, who showed a complete response to multiple applications of an interdisciplinary therapy.
참고문헌 (11)
- Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2016", Cancer Research and Treatment, 48(2), pp.451~457 (2016), 대한암학회
- Siegel RL, "Cancer statistics, 2016", CA Cancer J Clin, 66, pp.7~30 (2016)
- Allaire M, "Advances in management of hepatocellular carcinoma", Curr Opin Oncol, 29, pp.288~295 (2017)
- Gomaa AI, "Recent advances in multidisciplinary management of hepatocellular carcinoma", World J Hepatol, 7, pp.673~687 (2015)
- Kim DW, "Hepatocellular carcinoma(HCC) : beyond sorafenib-chemotherapy", J Gastrointest Oncol, 8, pp.256~265 (2017)
- Llovet JM, "Sorafenib in advanced hepatocellular carcinoma", N Engl J Med, 359, pp.378~390 (2008)
- Keating GM, "Sorafenib : a review of its use in advanced hepatocellular carcinoma", Drugs, 69, pp.223~240 (2009)
- Lu LC, "Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma : a national population study", Anticancer Res, 37, pp.2593~2599 (2017)
- Moriguchi M, "A review of non-operative treatments for hepatocellular carcinoma with advanced portal vein tumor thrombus", J Clin Trandl Hepatol, 5, pp.177~183 (2017)
- Kim SB, "Diffuse infiltrative hepatocellular carcinoma with portal vein tumor thrombosis completely cured by transcatheter arterial chemoembolization : case report with 8-year follow-up", Case Rep Gastroenterol, 10, pp.623~628 (2016)